GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (XCNQ:TELI) » Definitions » EBIT

Telescope Innovations (XCNQ:TELI) EBIT : C$-1.64 Mil (TTM As of Nov. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Telescope Innovations EBIT?

Telescope Innovations's earnings before interest and taxes (EBIT) for the three months ended in Nov. 2024 was C$-0.28 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Nov. 2024 was C$-1.64 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Telescope Innovations's annualized ROC % for the quarter that ended in Nov. 2024 was -22.83%. Telescope Innovations's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2024 was -33.21%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Telescope Innovations's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Nov. 2024 was -8.38%.


Telescope Innovations EBIT Historical Data

The historical data trend for Telescope Innovations's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telescope Innovations EBIT Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23 Aug24
EBIT
Get a 7-Day Free Trial -0.14 -4.02 -5.76 -0.72 -1.09

Telescope Innovations Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 -0.46 -0.12 -0.78 -0.28

Competitive Comparison of Telescope Innovations's EBIT

For the Biotechnology subindustry, Telescope Innovations's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telescope Innovations's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's EV-to-EBIT falls into.


;
;

Telescope Innovations EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telescope Innovations  (XCNQ:TELI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Telescope Innovations's annualized ROC % for the quarter that ended in Nov. 2024 is calculated as:

ROC % (Q: Nov. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Aug. 2024 ) + Invested Capital (Q: Nov. 2024 ))/ count )
=-1.064 * ( 1 - 0% )/( (4.653 + 4.67)/ 2 )
=-1.064/4.6615
=-22.83 %

where

Note: The Operating Income data used here is four times the quarterly (Nov. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Telescope Innovations's annualized ROC (Joel Greenblatt) % for the quarter that ended in Nov. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Nov. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Aug. 2024  Q: Nov. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-1.128/( ( (3.285 + max(-0.174, 0)) + (3.508 + max(-1.297, 0)) )/ 2 )
=-1.128/( ( 3.285 + 3.508 )/ 2 )
=-1.128/3.3965
=-33.21 %

where Working Capital is:

Working Capital(Q: Aug. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1.55 + 0.305 + 0.116) - (0.778 + 1.367 + 0)
=-0.174

Working Capital(Q: Nov. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.519 + 0.223 + 0.093) - (0.97 + 1.162 + 4.4408920985006E-16)
=-1.297

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Nov. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Telescope Innovations's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Nov. 2024 )
=-1.64/19.572
=-8.38 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telescope Innovations EBIT Related Terms

Thank you for viewing the detailed overview of Telescope Innovations's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Telescope Innovations Business Description

Traded in Other Exchanges
Address
2386 East Mall, Suite 301, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company that intends to focus on development as a Contract Research Organization (CRO) to develop intellectual property, contract research, and building automation products. The company has one operating segment that generates revenues from two revenue streams, contract research services and sale of automation products.
Executives
Jason Hein Director, Senior Officer
Alidad Pejman Director

Telescope Innovations Headlines

No Headlines